Search

everythinglearnresearchcommunity

for

Search:↓

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Restolin Hair Supplement may help hair growth but lacks FDA approval and clinical trial evidence.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness and are not FDA-approved.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.